Loading...
Combination of “low-dose” ribavirin and interferon alfa-2a therapy followed by interferon alfa-2a monotherapy in chronic HCV-infected non-responders and relapsers after interferon alfa-2a monotherapy
AIM: To report on the efficacy, safety and tolerability of interferon alfa-2a combined with a “low dose” of ribavirin for relapsers and non-responders to alpha interferon monotherapy. METHODS: Thirty four chronic hepatitis C virus infected non responders to interferon alfa-2a monotherapy (a course o...
Na minha lista:
| Udgivet i: | World J Gastroenterol |
|---|---|
| Main Authors: | , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Baishideng Publishing Group Inc
2001
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4723526/ https://ncbi.nlm.nih.gov/pubmed/11819764 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v7.i2.222 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|